Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
01/2002
01/23/2002CN1332728A Improved pyridine/picoline production process
01/23/2002CN1332723A Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them
01/23/2002CN1332154A Carbamate compound and its prep.
01/23/2002CN1078204C Amino acid amide derivative and fungicidal use and production process thereof
01/22/2002US6340772 Process for preparing (hetero) aromatic substituted benzene derivatives
01/22/2002US6340730 Catalytic olefin polymerization using metallocene metal catalysts
01/22/2002US6340691 Treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection
01/22/2002US6340682 Diamide compound and drugs containing the same
01/22/2002US6340371 Cationic ortho-phenylenediamines, their use for the oxidation dyeing of keratin fibers, dye compositions and dyeing processes
01/22/2002CA2095881C 2-formylpyridine thiosemicarbazone antitumor agents
01/22/2002CA2064872C Aryloxymethylcarbonochloridate ester intermediates, their production and use in synthesizing prodrugs and their use therefor
01/21/2002CA2353353A1 Novel heteroaryl derivatives and their use as medicaments
01/17/2002WO2002004626A1 Fungal cell wall synthesis gene
01/17/2002WO2002004421A2 Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
01/17/2002WO2002004419A2 α,α-DIBROMO-α-CHLORO-ACETOPHENONES AS SYNTHONS
01/17/2002WO2002004412A2 Tyrosine derivatives as phosphatase inhibitors
01/17/2002WO2002004407A2 7-substituted tetracycline compounds
01/17/2002WO2002004404A2 7,8 and 9-substituted tetracycline compounds
01/17/2002WO2002003995A2 Treatment of male sexual dysfunction
01/17/2002WO2002003912A2 Novel c-4 substituted retinoids
01/17/2002WO2001055107A3 Aromatic amines and amides acting on the melanocortin receptors
01/17/2002WO2001042211A3 Detection of transmembrane potentials by optical methods
01/17/2002WO2001038303A3 Vitamin d analogues
01/17/2002WO2001034602A3 Process and intermediates for the preparation of imidazolidinone alpha v integrin antagonists
01/17/2002WO2001005763A3 Compounds with activity on muscarinic receptors
01/17/2002US20020007070 For inhibiting loss of blood platelets; inhibiting formation of blood platelet aggregates, fibrin, thrombus, and embolus; anticoagulants embedded in devices for blood collection, circulation, storage (catheters, dialysis machines); stents
01/17/2002US20020007069 Reacting 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl) methyl)thio)benzimidazole with 3-chloroperoxybenzoic acid in ethyl acetate; purifying by dissolving in methylamine and by precipitation via addition of hydrochloric acid; purity
01/17/2002US20020007045 For inhibiting the aggregation of blood platelets; 3-(4-Aminomethyl-phenyl)-1-(2-(3,4-dichloro-phenyl)-2-hydroxy-ethyl)-1 -isopropyl-urea for example
01/17/2002US20020006958 Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof
01/17/2002US20020006951 Solid-state form of celecoxib having enhanced bioavailability
01/17/2002US20020006929 Antiarrhythmia agent, antiproliferative agent
01/17/2002US20020006924 Mixture of fipronil and antagonist of nicotenic acetylcholine receptors
01/17/2002US20020006922 Metalloprotease inhibitors
01/17/2002DE10033337A1 Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenylcarbonsäureamide, their preparation and their use as medicaments
01/17/2002CA2415569A1 Fungal cell wall synthesis gene
01/17/2002CA2415459A1 .alpha.,.alpha.-dibromo-.alpha.-chloro-acetophenones as synthons
01/17/2002CA2415086A1 7,8 and 9-substituted tetracycline compounds
01/17/2002CA2414188A1 Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
01/17/2002CA2414112A1 Treatment of male sexual dysfunction
01/16/2002EP1171423A1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
01/16/2002EP1171422A1 Mmp inhibitor
01/16/2002EP1171414A1 Compounds, their preparation and use
01/16/2002EP1171127A2 Pharmaceutical compositions containing pyridine or pyrimidine derivatives for inhibition of cytokine production and secretion
01/16/2002EP1019095B1 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
01/16/2002CN1331680A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors
01/16/2002CN1077886C Amidino derivatives useful as nitric oxide synthase inhibitors
01/16/2002CN1077792C Pyridylbisphosphonates for use as therapeutical agent
01/15/2002US6339097 N-phenylamide and N-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them
01/15/2002US6339091 Useful in therapy of of viral infections, parasitic diseases and cancer
01/15/2002US6339087 For therapy of inflammatory or allergic diseases are selected from asthma, allergic rhinitis, hypersensitivity lung diseases, hypersensitivity pneumonitis, eosinophilic pneumonias, inflammatory bowel diseases, psoriasis, dermatitis
01/15/2002US6339085 For therapy of hypertrophy, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, heart failure subsequent to myocardial infarction, myocardial infarction, ischemia reperfusion injury, blood coagulation
01/15/2002US6339081 Composition and use
01/15/2002US6339045 Can be used in a small amount, showing a good selectivity between crop and weed, and causing no phytotoxicity
01/15/2002US6338742 Crystallization process
01/10/2002WO2002002714A2 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
01/10/2002WO2002002550A1 Novel pyrazinone derivatives
01/10/2002WO2002002539A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
01/10/2002WO2002002528A1 Chemical process for the extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole
01/10/2002WO2002002527A1 Benzoylpyridine derivative or its salt, fungicide containing it as an active ingredient, its production process and intermediate for producing it
01/10/2002WO2002002519A2 THROMBIN OR FACTOR Xa INHIBITORS
01/10/2002WO2002002516A2 Inhibitors of hiv integrase
01/10/2002WO2002002515A1 Hydrazone derivatives effective in pest control or salts thereof
01/10/2002WO2002002513A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
01/10/2002WO2002002512A2 Compounds to treat alzheimer's disease
01/10/2002WO2002002486A1 Process for the preparation of polyhydric alcohols
01/10/2002WO2001068586A3 α4β1 AND α4β7 INTEGRIN INHIBITORS
01/10/2002US20020004522 Nervous system disorders
01/10/2002CA2414881A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
01/10/2002CA2414461A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
01/10/2002CA2413241A1 Thrombin or factor xa inhibitors
01/10/2002CA2413002A1 Novel pyrazinone derivatives
01/10/2002CA2411624A1 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
01/10/2002CA2410651A1 Compounds to treat alzheimer's disease
01/09/2002EP1170281A1 1,1- and 1,2-disubstituted cyclopropanes, process for their preparation and pharmaceutical compositions thereof
01/09/2002EP1170273A1 Alkynic compounds, their use as monomers in vacuum deposition polymerisation, thin films formed from these polymers and their use in electroluminescent devices
01/09/2002EP1169322A1 Pyridoxal analogues for vitamin b-6 disorders
01/09/2002EP1169312A2 Glucokinase activators
01/09/2002EP1169306A1 Dibenzoazulene derivatives for treating thrombosis, osteoporosis, arteriosclerosis
01/09/2002EP1169293A1 Liquid crystal compounds
01/09/2002EP1169040A2 Flupirtine in the treatment of fibromyalgia and related conditions
01/09/2002EP1169038A1 Cyclic protein tyrosine kinase inhibitors
01/09/2002EP1169031A1 Antimicrobial agents
01/09/2002EP0791034B1 Methine and azamethine dyes made from trifluoromethylpyridones
01/09/2002EP0639190B1 Pyridine sulfonyl urea derivatives
01/09/2002CN1330631A Amide derivatives which are useful as cell factor inhibitors
01/09/2002CN1330072A Intermediate for preparing 1-[halogenarylradical] heterocyclic pesticide compound
01/09/2002CN1330068A Method for preparing pyridine alkalis
01/09/2002CN1330067A 1,1-and 1,2-twice subsitituted cyclopropane compound, preparation method thereof and drug composite containing their
01/09/2002CN1330063A Propanedione derivative and use as polymerized ultraviolet absorber
01/09/2002CN1329888A Method for preparing medicine containing substitution pyridyl dihydric heptene acid or it salt
01/08/2002US6337417 Imidoyl chloride derivative chemical intermediates that are not harmful to crops
01/08/2002US6337398 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
01/08/2002US6337350 Inhibitors of formation of advanced glycation endproducts (AGEs)
01/08/2002US6337348 Inhibiting motility of sperm with oxovanadium compound with 1,10-phenanthroline, 2,2'bipyridine, 2'hydroxyacetophenone or 3-hydroxypropenal for complexes
01/08/2002US6337306 Herbicides for agriculture
01/08/2002US6337305 Substituted 2-benz(o)ylpyridines, their preparation and their use as herbicides
01/08/2002US6337034 Vinylene compounds and liquid-crystal composition
01/08/2002CA2080140C Photodynamic plant defoliants and chlorophyll biosynthesis modulators
01/03/2002WO2002000683A2 Novel chain-breaking antioxidants
01/03/2002WO2002000612A1 Glucagon antagonists/inverse agonists